BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8353403)

  • 1. Repertoires of autoantibodies against homologous eye muscle in ocular and generalized myasthenia gravis differ.
    Zimmermann CW; Eblen F
    Clin Investig; 1993 Jun; 71(6):445-51. PubMed ID: 8353403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody.
    Apinyawasisuk S; Chongpison Y; Thitisaksakul C; Jariyakosol S
    Am J Ophthalmol; 2020 Jan; 209():10-17. PubMed ID: 31562855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity in ocular and generalised myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT; Lawton J; Luciani G; McLeod J; Bradley J; Genkins G; Teng CS
    J Neuroimmunol; 1981 Sep; 1(3):325-32. PubMed ID: 7334085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
    Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
    Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Heat Shock Protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barré syndrome.
    Helgeland G; Petzold A; Hoff JM; Gilhus NE; Plant GT; Romi FR
    J Neuroimmunol; 2010 Aug; 225(1-2):180-3. PubMed ID: 20554026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis.
    Wang ZY; Okita DK; Howard J; Conti-Fine BM
    Neurology; 1998 Apr; 50(4):1045-54. PubMed ID: 9566393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.
    Feng X; Huan X; Yan C; Song J; Lu J; Zhou L; Wu H; Qiao K; Lu J; Xi J; Luo S; Zhao C
    Eur Neurol; 2020; 83(2):182-188. PubMed ID: 32526733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to treatment in pediatric ocular myasthenia gravis.
    Xu L; Castro D; Reisch JS; Iannaccone ST
    Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular myasthenia gravis: predictive value of single-fiber electromyography.
    Weinberg DH; Rizzo JF; Hayes MT; Kneeland MD; Kelly JJ
    Muscle Nerve; 1999 Sep; 22(9):1222-7. PubMed ID: 10454717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative modifications of blood serum proteins in myasthenia gravis.
    Adamczyk-Sowa M; Bieszczad-Bedrejczuk E; Galiniak S; Rozmiłowska I; Czyżewski D; Bartosz G; Sadowska-Bartosz I
    J Neuroimmunol; 2017 Apr; 305():145-153. PubMed ID: 28284335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study.
    Hendricks TM; Bhatti MT; Hodge DO; Chen JJ
    Am J Ophthalmol; 2019 Sep; 205():99-105. PubMed ID: 31077669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of autoantibodies associated with rippling muscles and myasthenia gravis that recognize skeletal muscle proteins: possible relationship of antigens and stretch-activated ion channels.
    Walker GR; Watkins T; Ansevin CF
    Biochem Biophys Res Commun; 1999 Oct; 264(2):430-5. PubMed ID: 10529381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the IgG autoantibody repertoire in endocrine ophthalmopathy using the MegaBlot technique.
    Grus FH; Augustin AJ
    Curr Eye Res; 1998 Jun; 17(6):636-41. PubMed ID: 9663853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-fiber Electromyography in the Extensor Digitorum Communis for the Predictive Prognosis of Ocular Myasthenia Gravis: A Retrospective Study of 102 Cases.
    Guan YZ; Cui LY; Liu MS; Niu JW
    Chin Med J (Engl); 2015 Oct; 128(20):2783-6. PubMed ID: 26481746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody profile may predict outcome in ocular myasthenia gravis.
    Galassi G; Mazzoli M; Ariatti A; Kaleci S; Valzania F; Nichelli PF
    Acta Neurol Belg; 2018 Sep; 118(3):435-443. PubMed ID: 29858757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Native gel electrophoresis and isoelectric focusing of a 64-kilodalton eye muscle protein shows that it is an important target for serum autoantibodies in patients with thyroid-associated ophthalmopathy and not expressed in other skeletal muscle.
    Wall JR; Hayes M; Scalise D; Stolarski C; Nebes V; Kiljanski J; Salvi M; Sato M
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1226-32. PubMed ID: 7714092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up.
    Kupersmith MJ
    J Neurol; 2009 Aug; 256(8):1314-20. PubMed ID: 19377863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different molecular expression in thymoma with ocular or generalized myasthenia gravis.
    Zhang M; Li H; Guo J; Zhou Y; Gong L; Wang X; Li Z; Zhang W
    J Neurol Sci; 2012 Feb; 313(1-2):27-31. PubMed ID: 22000402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.